275 related articles for article (PubMed ID: 25261502)
1. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.
Young AC; Yiannoutsos CT; Hegde M; Lee E; Peterson J; Walter R; Price RW; Meyerhoff DJ; Spudich S
Neurology; 2014 Oct; 83(18):1592-600. PubMed ID: 25261502
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
[TBL] [Abstract][Full Text] [Related]
5. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection.
Sailasuta N; Ross W; Ananworanich J; Chalermchai T; DeGruttola V; Lerdlum S; Pothisri M; Busovaca E; Ratto-Kim S; Jagodzinski L; Spudich S; Michael N; Kim JH; Valcour V;
PLoS One; 2012; 7(11):e49272. PubMed ID: 23229129
[TBL] [Abstract][Full Text] [Related]
6. A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.
Chang L; Lee PL; Yiannoutsos CT; Ernst T; Marra CM; Richards T; Kolson D; Schifitto G; Jarvik JG; Miller EN; Lenkinski R; Gonzalez G; Navia BA;
Neuroimage; 2004 Dec; 23(4):1336-47. PubMed ID: 15589098
[TBL] [Abstract][Full Text] [Related]
7. Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART.
Harezlak J; Cohen R; Gongvatana A; Taylor M; Buchthal S; Schifitto G; Zhong J; Daar ES; Alger JR; Brown M; Singer EJ; Campbell TB; McMahon D; So YT; Yiannoutsos CT; Navia BA;
J Neurovirol; 2014 Jun; 20(3):294-303. PubMed ID: 24696364
[TBL] [Abstract][Full Text] [Related]
8. Neurometabolic Remodeling in Chronic Hiv Infection: a Five-Year Follow-up Multi-Voxel Mrs Study.
Boban J; Thurnher MM; Brkic S; Lendak D; Bugarski Ignjatovic V; Todorovic A; Kozic D
Sci Rep; 2019 Dec; 9(1):19799. PubMed ID: 31875001
[TBL] [Abstract][Full Text] [Related]
9. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
[TBL] [Abstract][Full Text] [Related]
10. Proton Chemical Shift Imaging Study of the Combined Antiretroviral Therapy Impact on Neurometabolic Parameters in Chronic HIV Infection.
Boban J; Kozic D; Turkulov V; Lendak D; Bjelan M; Semnic M; Brkic S
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1122-1129. PubMed ID: 28428210
[TBL] [Abstract][Full Text] [Related]
11. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
Sailasuta N; Ananworanich J; Lerdlum S; Sithinamsuwan P; Fletcher JL; Tipsuk S; Pothisri M; Jadwattanakul T; Jirajariyavej S; Chalermchai T; Catella S; Busovaca E; Desai A; Paul R; Valcour V;
J Acquir Immune Defic Syndr; 2016 Jan; 71(1):24-30. PubMed ID: 26258565
[TBL] [Abstract][Full Text] [Related]
12. Cerebral metabolites in HIV-infected children followed for 10 months with 1H-MRS.
Keller MA; Venkatraman TN; Thomas MA; Deveikis A; Lopresti C; Hayes J; Berman N; Walot I; Ernst T; Chang L
Neurology; 2006 Mar; 66(6):874-9. PubMed ID: 16567705
[TBL] [Abstract][Full Text] [Related]
13. HIV-related metabolic abnormalities in the brain: depiction with proton MR spectroscopy with short echo times.
Laubenberger J; Häussinger D; Bayer S; Thielemann S; Schneider B; Mundinger A; Hennig J; Langer M
Radiology; 1996 Jun; 199(3):805-10. PubMed ID: 8638009
[TBL] [Abstract][Full Text] [Related]
14. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
[TBL] [Abstract][Full Text] [Related]
15. Short echo time multislice proton magnetic resonance spectroscopic imaging in human brain: metabolite distributions and reliability.
Wiedermann D; Schuff N; Matson GB; Soher BJ; Du AT; Maudsley AA; Weiner MW
Magn Reson Imaging; 2001 Oct; 19(8):1073-80. PubMed ID: 11711231
[TBL] [Abstract][Full Text] [Related]
16. A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease.
Scott J; Underwood J; Garvey LJ; Mora-Peris B; Winston A
Br J Radiol; 2016; 89(1060):20150979. PubMed ID: 26954329
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals.
Letendre SL; Zheng JC; Kaul M; Yiannoutsos CT; Ellis RJ; Taylor MJ; Marquie-Beck J; Navia B;
J Neurovirol; 2011 Feb; 17(1):63-9. PubMed ID: 21246320
[TBL] [Abstract][Full Text] [Related]
18. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities.
Chang L; Ernst T; Speck O; Grob CS
Am J Psychiatry; 2005 Feb; 162(2):361-9. PubMed ID: 15677602
[TBL] [Abstract][Full Text] [Related]
19. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
20. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
